| 1. |
Hujdik, W. P. N., Sakariassen, K. S., Nievelstein, P. F. E. M., and Sixma, J. J. (1985) Role of factor VII-von Willebrand
factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar collagens types I and
III. J. Clin. Inv.
75, 531–540.
|
| |
| 2. |
Nieuwenhuis, H. K., Akkerman, J. W. N., Houdijk, W. P. M., and Sixma, J. J. (1985) Human blood platelets showing no response
to collagen fail to express surface glycoprotein-Ia. Nature
318, 470–472.
|
| |
| 3. |
Hotkotter, O., Nieswandt, B., Smyth, N., Muller, W., Hafner, M., Schulte, V., et al. (2002) Integrin α2-deficient mice develop normally, are fertile, but display partially defective interaction with collagen. J. Biol. Chem.
277, 10,789–10,794.
|
| |
| 4. |
Nieswandt, B., Brakebusch, C., Bergmeier, W., Schulte, V., Bouvard, D., Mokhtari-Nejad, R., et al. (2001) Glycoprotein VI
but not α2β1 integrin is essential for platelet interaction with collagen. EMBO J.
20, 2120–2130.
|
| |
| 5. |
Gibbins, J., Asselin, J., Farndale, R., Barnes, M., Law, C. L., and Watson, S. P. (1996) Tyrosine phosphorylation of the Fc
receptor γ-chain in collagen-stimulated platelets. J. Biol. Chem.
271, 18,095–18,099.
|
| |
| 6. |
Asselin, J., Gibbins, J. M., Achison, M., Lee, Y.-H., Morton, L. F., Farndale, R. W., et al. (1997) A collagen-like peptide
stimulates tyrosine phosphorylation of syk and phospholipase Cγ2 in platelets independent of the integrin α2β1. Blood
89, 1235–1242.
|
| |
| 7. |
Gibbins, J. M., Okuma, M., Farndale, R., Barnes, M., and Watson, S. P. (1997) Glycoprotein VI is the collagen receptor in
platelets which underlies tyrosine phosphorylation of the Fc receptor γ-chain. FEBS Lett.
413, 255–259.
|
| |
| 8. |
Poole, A., Gibbins, J. M., Turner, M., van Vugt, M. J., van mnde Winkel, J. G. J., Saito, T., et al. (1997) The Fc receptor
γ-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J.
16, 2333–2341.
|
| |
| 9. |
Depraetere, H., Ajzenberg, N., Girma, J. P., Lacombe, C., Meyer, D., Deckmyn, H., et al. (1998) Platelet aggregation induced
by a monoclonal antibody to the A1 domain of von Willebrand factor. Blood
91, 3792–3799.
|
| |
| 10. |
Knight, C. G., Morton, L. F., Onley, D. J., Peachey, A. R., Messent, A. J., Smethurst, P. A., et al. (1998) Identification
in collagen type I of an integrin α2β1-binding site containing an essential GER sequence. J. Biol. Chem.
273, 33,287–33,294.
|
| |
| 11. |
Smith, C., Estavillo, D., Emsley, J., Bankston, L. A., Liddington, R. C., and Cruz, M. A. (2000) Mapping the collagen-binding
site in the I domain of the glycoprotein Ia/IIa (integrin α2β1). J. Biol. Chem.
275, 4205–4209.
|
| |
| 12. |
Huai, J. and Drescher, U. (2001) An ephrin-A-dependent signaling pathway controls integrin function and is linked to the tyrosine
phosphorylation of a 120-kDa protein. J. Biol. Chem.
276, 6689–6694.
|
| |
| 13. |
Vossmeyer, D., Hofmann, W., Loster, K., Reutter, W., and Danker, K. (2002) Phospholipase Cγ binds α2β1 integrin and modulates α2β1 integrin-specific adhesion. J. Biol. Chem.
277, 4636–4643.
|
| |
| 14. |
Onley, D. J., Knight, C. G., Tuckwell, D. S., Barnes, M., and Farndale, R. W. (2000) Micromolar Ca2+ concentrations are essential for Mg2+-dependent binding of collagen by the integrin α2β1 in human platelets. J. Biol. Chem.
275, 24,560–24,564.
|
| |
| 15. |
Prevost, N., Woulfe, D., Tanaka, T., and Brass, L. F. (2002) Interactions between Eph kinases and ephrins provide a mechanism
to support platelet aggregation once cell-to-cell contact has occurred. PNAS
99, 9219–9224.
|
| |
| 16. |
Santoro, S. A., Zutter, M. M., Wu, J. E., Staatz, W. D., Saelman, E. U. M., and Keely, P. J. (1994) Analysis of Collagen Receptors
in Extracellular Matrix Components (Ruoslahti, E., ed.), Methods in Enzymology Vol. 245, Academic Press, San Diego, CA, pp. 147–183.
|
| |
| 17. |
Haverstick, D. M., Cowan, J. F., Yamada, K. M., and Santoro, S. A. (1985) Inhibition of platelet adhesion to fibronectin,
fibrinogen and von Willebrand factor substrates by a synthetic tetrapeptide derived from the cell-binding domain of fibronectin.
Blood
66, 946–952.
|
| |